← Eichor
Condition: Regurgitation Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Regurgitation

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

MiCLASP Post Market Clinical Follow-Up (PMCF) Study
Phase N/A · 37 location(s) · Edwards Lifesciences · NCT04430075Comparison of Transcatheter Edge-to-edge Repair Using Echo Only with Echo Combined with X Ray for Mitral Regurgitation (
NA · 1 location(s) · Pan Xiangbin · NCT06684171Innoventric Trillium™ Stent Graft Early Feasibility Study (EFS)
NA · 12 location(s) · Innoventric LTD · NCT06212193Tricuspid RegUrgitaTion Hamburg Cohort
Phase N/A · 1 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT04755842An Early Feasibility Study of the HighLife 28mm Trans-Septal Transcatheter Mitral Valve Replacement System
NA · 10 location(s) · HighLife SAS · NCT04029337CHoice of OptImal transCatheter trEatment for Mitral Insufficiency Registry
Phase N/A · 43 location(s) · Universitätsklinikum Hamburg-Eppendorf · NCT04688190SQ-Kyrin TMVr FIM Study
NA · 1 location(s) · Shanghai Shenqi Medical Technology Co., Ltd · NCT05040074Annuloplasty Rings and Band Post-Market Clinical Follow-Up Study
Phase N/A · 17 location(s) · Abbott Medical Devices · NCT04761120Study of the Clinical Impact of Surgical Correction of Tricuspid Insufficiency in Implantable LVAD Patients
NA · 1 location(s) · University of Washington · NCT02537769TriRec - Trileaflet Reconstruction of the Aortic Valve With Autologous Pericardium
NA · 1 location(s) · Deutsches Herzzentrum Muenchen · NCT03600662Safety and Feasibility Study: Transcatheter Valve Repair in Severe Symptomatic Functional Tricuspid Regurgitation
NA · 1 location(s) · Tangent Cardiovascular Inc. · NCT07140562Safety and Effectiveness Study of DragonFly-T System for Severe Tricuspid Regurgitation
NA · 2 location(s) · Hangzhou Valgen Medtech Co., Ltd · NCT05556460Valveclip® Transcatheter Mitral Valve Repair Study
NA · 1 location(s) · Shanghai NewMed Medical Co., Ltd. · NCT05021614Secondary Mitral Regurgitation Treatment With MitraClip and Assessment by Cardiac Magnetic Resonance
Phase N/A · 6 location(s) · Minneapolis Heart Institute Foundation · NCT07131631Investigation of Gastric Emptying by Gastric Ultrasonography in Diabetic Patients Treated With GLP-1 Receptors
Phase N/A · 1 location(s) · University Hospital, Geneva · NCT07506356DragonFly EU Pivotal Study
NA · 1 location(s) · Hangzhou Valgen Medtech Co., Ltd · NCT05927441European Registry of Transcatheter Repair for Tricuspid Regurgitation
Phase N/A · 1 location(s) · LMU Klinikum · NCT06307262Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR)
Phase N/A · 22 location(s) · University Hospital of Cologne · NCT06911099Pacemaker Implantation Following Transcatheter Tricuspid Valve Replacement
Phase N/A · 1 location(s) · Deutsches Herzzentrum Muenchen · NCT06814574The TRICURE EFS Study
NA · 10 location(s) · TRiCares · NCT06506942Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial
NA · 79 location(s) · Edwards Lifesciences · NCT04097145Feasibility Study of the Tioga TMVR System
NA · 5 location(s) · Tioga Cardiovascular, Inc. · NCT06038838Expanded Study of the HighLife 28mm Trans-septal Trans-catheter Mitral Valve in Patients With Moderate-severe or Severe
NA · 50 location(s) · HighLife SAS · NCT04029363TriClip CED RWE Study
Phase N/A · 1 location(s) · Abbott Medical Devices · NCT06920745Sodium-Glucose Cotransporter 2 Inhibitors for Repaired Tetralogy of Fallot Patients for Enhancement of Cardio-Pulmonary
Phase 4 · 1 location(s) · The University of Hong Kong · NCT06668389Cohort Observing Mechanisms, Progression and Sequelae of Valvular Heart Disease
Phase N/A · 15 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07267117Efficacy and Safety of Catheter abLation in patiEnts With seVere mitrAl regurgiTation and pErsistent Atrial Fibrillation
NA · 17 location(s) · Beijing Anzhen Hospital · NCT06883864Novel 3-dimensional Echocardiographic Quantification of Mitral Regurgitant Volume
Phase N/A · 1 location(s) · Germans Trias i Pujol Hospital · NCT07528781Characteristics and Prognosis of Moderate or Severe Tricuspid Regurgitation
Phase N/A · 1 location(s) · Centre Hospitalier Universitaire, Amiens · NCT03546231A Clinical Study of GeminiOne TEER System for the Treatment of Severe, Symptomatic MR.
NA · 1 location(s) · Sierra Valve LLC · NCT07086534
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.